Upregulation of the citrullinating enzyme PAD2 in the lung tissues of patients with RA-ILD is controlled by syndecan-2 via regulation of the PI3K/Akt/Sp1 pathway, which is dependent on CD148 [95]. The gene discussed is AKT1; the disease is rheumatoid arthritis.